慢性非侵入性通风在COPD:朝着识别一个响应的表型响应的方向
Tim Raveling1,2, Jorine E Hartman1,2, Renzo Boersma1,2
1Department of Pulmonary Diseases and Home Mechanical Ventilation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
ERJ open research
|October 29, 2025
概括
慢性非侵入性通风 (NIV) 改善了COPD患者的生活质量,但反应各不相同. 集群分析确定了不同的患者群体,指导个性化治疗策略,以获得慢性高头症的更好的结果.
科学领域:
- 肺部医学 肺部医学
- 呼吸系统护理 呼吸系统护理
- 生活质量研究 研究 生命质量研究
背景情况:
- 慢性非侵入性通风 (NIV) 是慢性COPD患者慢性高头的关键治疗方法.
- 关于与健康相关的生活质量 (HRQoL) 的个人对NIV的反应显示出显著的变化.
- 识别具有不同HRQoL反应的患者子组对于优化NIV治疗至关重要.
研究的目的:
- 根据HRQoL对慢性NIV的反应来识别不同的患者群.
- 通过其临床和疾病特征来表征这些患者群.
- 为了告知COPD慢性高头的个性化治疗方法.
主要方法:
- 对慢性NIV表示COPD患者的前性随访.
- 测量气体交换,肺功能,运动能力和HRQoL (使用SRI) 在基线和6个月.
- 使用自我组织地图-沃德的方法对患者按HRQoL响应分组的集群分析.
主要成果:
- 根据HRQoL对NIV的反应,出现了三个不同的患者群.
- "良好的反应者"显示了显著的HRQoL改善,高恶化,低基线HRQoL和情绪障碍.
- "响应不佳者"经历了HRQoL恶化和生存能力受损,经常出现严重的肺功能障碍,但并发症较少.
结论:
- 慢性NIV似乎对有频繁恶化,严重HRQoL损伤和情绪障碍的COPD患者最有益.
- 鉴定到的集群突出显示了NIV反应在COPD中的异质性.
- 需要进一步的研究,包括RCT,以确认NIV与不同患者群体观察到的HRQoL反应之间的因果关系.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
COPD: Management Using Bronchodilators and Corticosteroids
719
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
719


